Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1986 Dec;21(12):733-7.
doi: 10.1007/BF02535403.

Comparative study of the blood pressure effects of four different vegetable fats on young, spontaneously hypertensive rats

Comparative Study

Comparative study of the blood pressure effects of four different vegetable fats on young, spontaneously hypertensive rats

P Hoffmann et al. Lipids. 1986 Dec.

Abstract

Following the suckling period, four groups of male four-week-old spontaneously hypertensive rats (SHR) were fed semisynthetic diets with 14% (by weight) of either sunflower seed oil [46% 18:2(n-6); linoleic acid (LA)-rich], linseed oil [62.5% 18:3(n-3) + 12.9% 18:2(n-6); alpha-linolenic acid (LNA)-rich], evening primrose oil [9.2% 18:3(n-6) + 71% 18:2(n-6); gamma-linolenic acid (LNA)-rich] or hydrogenated palm kernel fat [1.5% 18:2(n-6); polyunsaturated fatty acid (PUFA)-deficient], respectively, up to an age of 18 wk. All diets enriched with PUFA provoked an attenuation of hypertension development. The effect was lowest in the LA-rich group and highest in the gamma-LNA-rich group. Differences in fatty acid composition of renal phospholipids between groups reflect the fatty acids present in the respective dietary fats. Renomedullary production of PGF2 alpha was significantly reduced in alpha-LNA-rich and slightly diminished in gamma-LNA-rich fed rats. Aortic formation of 6-keto-PGF1 alpha and TXB2 was increased in animals fed the gamma-LNA-rich diet. Thus, the attenuation of hypertension development cannot be explained only by changes in prostanoid formation. Other mechanisms possibly involved should be pursued.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Pharmacol Res Commun. 1981 Apr;13(4):363-83 - PubMed
    1. Prostaglandins Leukot Med. 1982 Mar;8(3):273-85 - PubMed
    1. Life Sci. 1981 Mar 16;28(11):1253-9 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 1981 Aug;317(1):78-80 - PubMed
    1. Arch Int Pharmacodyn Ther. 1975 Jul;216(1):160-4 - PubMed

Publication types

LinkOut - more resources